InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
RNAC
Result 168 decisions over 120 months
Reset filters
Direction ?
Both168 Bought87 Sold81
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: RNAC
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
RNAC Cartesian Therapeutics, Inc.
20 Sep 2017
Nashat Amir
Director indirect
Sold, plan not stated 4×
42,610
$853.39K
77.6%
RNAC Cartesian Therapeutics, Inc.
20 Sep 2017
Siewers David
CFO and Treasurer
Sold, plan not stated 2×
16,424
$328.48K
100%
RNAC Cartesian Therapeutics, Inc.
3 Jul 2017
Johnston Lloyd P.
COO and SVP, R*D
Sold, plan not stated 2×
5,959
$113.81K
78.8%
RNAC Cartesian Therapeutics, Inc.
30 Jun 2017
Siewers David
Chief Financial Officer
Sold, plan not stated
7,420
$148.41K
100%
RNAC Cartesian Therapeutics, Inc.
29 Jun 2017
Siewers David
Chief Financial Officer
Sold, plan not stated 2×
9,652
$193.04K
100%
RNAC Cartesian Therapeutics, Inc.
27 Jun 2017
SPRINGER TIMOTHY A
Director
Bought
338,791
$6.00M
×20
RNAC Cartesian Therapeutics, Inc.
27 Jun 2017
Keller Peter
Chief Business Officer
Sold, plan not stated
4,595
$88.68K
91.9%
RNAC Cartesian Therapeutics, Inc.
26 Jun 2017
Siewers David
Chief Financial Officer
Sold, plan not stated
6,886
$137.72K
99.5%
RNAC Cartesian Therapeutics, Inc.
15 Jun 2017
Johnston Lloyd P.
COO and SVP, R*D
Sold, plan not stated
20,512
$348.64K
92.7%
RNAC Cartesian Therapeutics, Inc.
1 Jun 2017
SPRINGER TIMOTHY A
Director
Bought
518
$7.12K
3.2%
RNAC Cartesian Therapeutics, Inc.
18 May 2017
SPRINGER TIMOTHY A
Director
Bought
4,860
$68.04K
43.2%
RNAC Cartesian Therapeutics, Inc.
17 May 2017
SPRINGER TIMOTHY A
Director
Bought
11,244
$157.48K
opened
RNAC Cartesian Therapeutics, Inc.
16 May 2017
Kania Edwin
Director indirect
Sold, plan not stated
266,795
$3.74M
32.3%
RNAC Cartesian Therapeutics, Inc.
17 Apr 2017
Johnston Lloyd P.
COO AND SVP, R&D
Sold, plan not stated
13,205
$184.21K
89.2%
RNAC Cartesian Therapeutics, Inc.
23 Jan 2017
Johnston Lloyd P.
COO AND SVP, R&D
Sold, plan not stated 2×
15,000
$210.11K
90.3%
RNAC Cartesian Therapeutics, Inc.
28 Dec 2016
Kishimoto Takashi Kei
Chief Scientific Officer
Sold, plan not stated
10,000
$175.50K
100%
RNAC Cartesian Therapeutics, Inc.
21 Dec 2016
Abraham David
CCO, Gen.Counsel, Corp.Sec.
Sold, plan not stated
14,844
$267.19K
100%
RNAC Cartesian Therapeutics, Inc.
19 Dec 2016
Keller Peter
Chief Business Officer
Sold, plan not stated
4,723
$87.75K
92.1%
Showing 151–168 of 168. ← Newer Page 4 of 4